PHARMANUTRA
Research PHARMANUTRA (PHN.MI) on Bullrun: market cap EUR 683.67M, P/E 33.4, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPHN.MI
- ExchangeMTAA
- CountryItaly
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 683.67M
- P/E33.4
- Dividend yield1.7%
- Financial periodQ1 2026
- RevenueEUR 33.35M
- Net incomeEUR 3.46M
- Free cash flowEUR 966.00K
- Gross margin73.9%
Valuation Snapshot
latest market cap is EUR 683.67M; P/E is 33.4; dividend yield is 1.7%.
Peer valuation comparison
Latest P/E is 33.36x versus a Healthcare sector median of 24.67x (35.3% above).
Latest dividend yield is 1.69% versus a Healthcare sector median of 1.84% (8.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 131.69M | EUR 20.00M | EUR 16.43M | 78.1% | 2090 | EUR 18.58M | EUR 20.51M | EUR 71.35M |
| FY2024 | EUR 115.50M | EUR 16.61M | n/a | n/a | 1730 | EUR 15.49M | n/a | EUR 62.16M |
| FY2023 | EUR 100.20M | EUR 12.83M | -EUR 1.16M | n/a | 1.33 | EUR 18.88M | n/a | EUR 54.41M |
| FY2022 | EUR 82.72M | EUR 15.05M | -EUR 8.69M | n/a | 1560 | EUR 22.05M | n/a | EUR 50.95M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-05 | EUR 683.67M | 33.4 | 1.7% | 1.2 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.2 EUR, yield 1.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1 EUR |
| FY2024 | 0.85 EUR |
| FY2023 | 0.8 EUR |
| FY2022 | 0.71 EUR |
About PHARMANUTRA
Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PHARMANUTRA's market cap?
PHARMANUTRA's market capitalization is EUR 683.67M.
What is PHARMANUTRA's P/E ratio?
PHARMANUTRA's price-to-earnings (P/E) ratio is 33.4.
Does PHARMANUTRA pay a dividend?
PHARMANUTRA has a dividend yield of 1.7%.
What does PHARMANUTRA do?
Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries.